BRIM Biotechnology Inc.
BRIM Biotechnology Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease | Conjunctival Diseases, conjunctivitis, corneal disorder, dry eye syndrome, eye disorder, keratitis, keratoconjunctivitis, lacrimal apparatus disorder | Not yet recruiting | Phase 2 | 2025-10-20 | NCT07078955 | |
| Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis | neurotrophic keratopathy | Recruiting | Phase 2 | 2024-10-28 | NCT05927428 |